| Primary |
| Product Used For Unknown Indication |
50.9% |
| Asthma |
11.4% |
| Pruritus |
6.3% |
| Hypersensitivity |
3.4% |
| Premedication |
3.4% |
| Rhinitis Allergic |
2.9% |
| Breast Cancer |
2.3% |
| Hypertension |
2.3% |
| Sjogren's Syndrome |
2.3% |
| Basedow's Disease |
1.7% |
| Prophylaxis |
1.7% |
| Rhinitis |
1.7% |
| Waldenstrom's Macroglobulinaemia |
1.7% |
| Contraception |
1.1% |
| Dermatosis |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Neuralgia |
1.1% |
| Rectal Cancer |
1.1% |
| Seasonal Allergy |
1.1% |
| Urticaria |
1.1% |
|
| Urticaria |
11.1% |
| Palpitations |
8.3% |
| Accidental Overdose |
5.6% |
| Hepatitis |
5.6% |
| Hypoglycaemia |
5.6% |
| Malaise |
5.6% |
| Neutropenia |
5.6% |
| No Adverse Event |
5.6% |
| Pancreatitis Acute |
5.6% |
| Somnolence |
5.6% |
| Swelling Face |
5.6% |
| Tachycardia |
5.6% |
| Vertigo |
5.6% |
| Agranulocytosis |
2.8% |
| Anogenital Warts |
2.8% |
| Balance Disorder |
2.8% |
| Epilepsy |
2.8% |
| Extrapyramidal Disorder |
2.8% |
| Glaucoma |
2.8% |
| Hepatic Steatosis |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.8% |
| Product Used For Unknown Indication |
26.7% |
| Asthma |
8.8% |
| Hypertension |
5.5% |
| Premedication |
4.2% |
| Hypersensitivity |
2.9% |
| Pruritus |
2.9% |
| Diabetes Mellitus |
2.6% |
| Hypopharyngeal Cancer |
2.2% |
| Migraine |
2.2% |
| Oropharyngeal Pain |
1.8% |
| Pneumonia Legionella |
1.8% |
| Pyrexia |
1.8% |
| Rash |
1.5% |
| Myotonia |
1.3% |
| Rash Pruritic |
1.3% |
| Rhinitis Allergic |
1.3% |
| Serum Ferritin Increased |
1.3% |
| Influenza |
1.1% |
| Pain |
1.1% |
|
| Agranulocytosis |
10.6% |
| Dyspnoea Exertional |
9.1% |
| Vomiting |
9.1% |
| Cytolytic Hepatitis |
7.6% |
| Infusion Related Reaction |
6.1% |
| Thrombocytopenia |
6.1% |
| Face Oedema |
4.5% |
| Hepatocellular Injury |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Prurigo |
4.5% |
| Renal Failure |
4.5% |
| Systemic Lupus Erythematosus |
4.5% |
| Aplasia Pure Red Cell |
3.0% |
| Erythema Infectiosum |
3.0% |
| Hepatic Steatosis |
3.0% |
| Hepatitis Cholestatic |
3.0% |
| Hyponatraemia |
3.0% |
| Infectious Mononucleosis |
3.0% |
| Lip Oedema |
3.0% |
| Photosensitivity Reaction |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
24.0% |
| Premedication |
7.6% |
| Hypertension |
7.1% |
| Asthma |
7.0% |
| Crohn's Disease |
3.0% |
| Hypersensitivity |
2.9% |
| Prophylaxis |
2.7% |
| Pain |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Hiv Infection |
2.0% |
| Multiple Myeloma |
1.9% |
| Depression |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Diabetes Mellitus |
1.4% |
| Ischaemic Cardiomyopathy |
1.4% |
| Pruritus |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Rash |
1.3% |
| Anxiety |
1.2% |
|
| Vomiting |
10.6% |
| Pyrexia |
8.7% |
| Urticaria |
8.7% |
| Renal Failure Acute |
7.9% |
| Rash |
6.7% |
| Toxic Skin Eruption |
6.7% |
| Weight Decreased |
5.5% |
| Thrombocytopenia |
5.1% |
| Rash Maculo-papular |
4.3% |
| International Normalised Ratio Increased |
3.9% |
| Somnolence |
3.9% |
| Rhabdomyolysis |
3.5% |
| Suicidal Ideation |
3.5% |
| Weight Increased |
3.5% |
| Idiopathic Thrombocytopenic Purpura |
3.1% |
| Renal Failure |
3.1% |
| Product Quality Issue |
2.8% |
| Thrombosis |
2.8% |
| Tremor |
2.8% |
| Vaginal Haemorrhage |
2.8% |
|
| Interacting |
| Hypertension |
27.3% |
| Hormone Therapy |
13.6% |
| Seasonal Allergy |
9.1% |
| Urticaria Chronic |
9.1% |
| Allergic Sinusitis |
4.5% |
| Antiandrogen Therapy |
4.5% |
| Cough |
4.5% |
| Cystitis |
4.5% |
| Dermatitis Allergic |
4.5% |
| Pneumonia |
4.5% |
| Pruritus |
4.5% |
| Rhinitis |
4.5% |
| Upper Respiratory Tract Infection |
4.5% |
|
| Extrapyramidal Disorder |
16.7% |
| Hepatitis |
16.7% |
| Hypoaesthesia |
16.7% |
| Joint Injury |
16.7% |
| Syncope |
16.7% |
| Urticaria |
16.7% |
|
